Literature DB >> 11305983

Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode.

A S Kurbaan1, T J Bowker, C D Ilsley, U Sigwart, A F Rickards.   

Abstract

In diabetics with coronary artery disease (CAD), there remains uncertainty as to whether revascularization by percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass surgery (CABG) is preferable. To address this, 4-year mortality and level of pre- and postrevascularization angiographic CAD (measured by a series of coronary scores) were compared between both diabetics and nondiabetics and between revascularization modes in the Coronary Angioplasty versus Bypass Revascularization Investigation population as a whole, and then substratified by diabetic status and then by procedure to which they were randomized. The 1,054 randomized subjects contained 125 diabetics (11.9%) who had significantly greater mortality than nondiabetics (RR 2.19, p = 0.001). Among diabetics or nondiabetics, there was no significant mortality difference between those randomized to PTCA versus those to CABG. Diabetics randomized to PTCA and those to CABG had higher mortalities than respective nondiabetics; the association reached significance only in the former (RR 2.41, p = 0.002). All subgroups had similar prerevascularization CAD. Postrevascularization residual CAD was consistently significantly greater in PTCA than in respective CABG subgroups. Most measurements of CAD were greater in diabetic than in nondiabetic subgroups, but none was significant. In the Coronary Angioplasty versus Bypass Revascularization Investigation, diabetics had double the mortality of nondiabetics; this difference was statistically significant both for the entire population and for those randomized to PTCA, but not for those randomized to CABG. Among diabetics or nondiabetics, there was no significant mortality difference between PTCA and CABG. The higher diabetic mortality was more likely related to more rapid disease progression than to greater postrevascularization disease.

Entities:  

Mesh:

Year:  2001        PMID: 11305983     DOI: 10.1016/s0002-9149(01)01426-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?

Authors:  P F Ludman
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

2.  Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Kan Kajimoto; Naozumi Kubota; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

3.  Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.

Authors:  Bora Toklu; Sripal Bangalore
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-05

Review 4.  Cardiovascular disease: much more aggressive in patients with type 2 diabetes.

Authors:  Elaine Chiquette; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

5.  Coronary intervention in diabetes: is it different.

Authors:  Amit Malviya; Animesh Mishra
Journal:  Heart Asia       Date:  2015-03-10

6.  Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes.

Authors:  M W Groot; S J Head; Ad J J C Bogers; A P Kappetein
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

Review 7.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

8.  Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR).

Authors:  Hyeon-Cheol Gwon; Seung Hee Choi; Byung-Il William Choi; Seung Yun Cho; Young Moo Ro; Won Ro Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  [Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].

Authors:  R Dörr; J Stumpf; J Dalibor; G Simonis; S G Spitzer
Journal:  Herz       Date:  2014-05       Impact factor: 1.443

10.  Optimal treatment of the diabetic patient with multivessel disease.

Authors:  Sameer Bansilal; Michael E Farkouh; Valentin Fuster
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.